Ginkgo Bioworks Holdings (DNA) Times Interest Earned (2020 - 2024)
Ginkgo Bioworks Holdings (DNA) reported Times Interest Earned of -$3.3 for Q4 2024, up 18.4% on a YoY basis from -$2.79 in Q1 2024, and down 155.35% quarter-over-quarter from $5.97 in Q3 2024.
Ginkgo Bioworks Holdings (DNA) Times Interest Earned (2020 - 2024) Analysis & Trends
Ginkgo Bioworks Holdings has reported Times Interest Earned for 4 years, with the latest figure at -$3.3 in Q4 2024.
- For the quarter ending Q4 2024, Times Interest Earned rose 18.4% year-over-year to -$3.3; the trailing twelve-month figure through Sep 2025 stood at -$10.84 (up 58.21% YoY), and the FY2024 full-year result was -$5954.9, up 35.93% from the prior year.
- Times Interest Earned for Q4 2024 stood at -$3.3, down from $5.97 in the prior quarter.
- The five-year high for Times Interest Earned was $21.62 in Q2 2024, with the low at -$3057.6 in Q4 2021.
- Historically, Times Interest Earned has averaged -$319.94 across 4 years, with a median of -$3.68 in 2023.
- Annual changes were most pronounced in 2021 — Times Interest Earned tumbled 3127.85% — and 2024, when it soared 68.45%.
- Ginkgo Bioworks Holdings' Times Interest Earned stood at -$94.73 in 2020, then plunged by 3127.85% to -$3057.6 in 2021, then surged by 99.87% to -$4.05 in 2023, then gained by 18.4% to -$3.3 in 2024.
- The last three Times Interest Earned figures came in at -$3.3 (Q4 2024), $5.97 (Q3 2024), and $21.62 (Q2 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 3.58 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 11.50 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -258.33 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 11.79 |
| 10 | Ginkgo Bioworks Holdings | 546.79 Mn | 546.79 Mn | 16.38 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -3.30 |
| Sep 30, 2024 | 5.97 |
| Jun 30, 2024 | 21.62 |
| Dec 31, 2023 | -4.05 |
| Sep 30, 2023 | 19.07 |
| Jun 30, 2023 | 12.83 |
| Dec 31, 2021 | -3,057.60 |
| Sep 30, 2021 | -41.10 |
| Dec 31, 2020 | -94.73 |
| Sep 30, 2020 | -58.13 |